RX
PrivateLast Round
Grant
Jul 1, 2026
Total Funding Raised
$2.39M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
RX operates in Energy & Sustainability and is based in Daejeon. Its latest recorded funding round was an Accelerator round in April 2026.
RX is a nuclear engineering company that specializes in Small Modular Reactor (SMR) design, licensing, and AI-powered plant solutions.
Sector
Energy & Sustainability
Verticals
Energy Management, Smart Grid, Renewable Energy, EV Charging
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RX Comparables
Compare RX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Camus Energy | 78% | |
| Oracle Corporation | 75% | |
| Mitsubishi Electric Corporation | 73% |
For institutional investors. Book with your work email.
RX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 1, 2026 | ||||
| Accelerator | Apr 1, 2026 | ||||
| Pre Seed | Jan 1, 2026 | ||||
| Grant | Oct 1, 2024 | ||||
| Seed | Aug 1, 2024 | ||||
Grant | Apr 1, 2024 |
For institutional investors. Book with your work email.
RX Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CKD Venture Capital | Seed, Pre Seed |
| A Ventures | Seed, Pre Seed |
| Bluepoint Partners | Seed, Pre Seed |
| Company K Partners | Seed, Pre Seed |
| Banks Foundation for Young Entrepreneurs | Accelerator |
| KT Investment | Seed, Pre Seed |
| Mirae Asset Venture Investment | Seed, Pre Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 18, 2026
Grew 500% QoQ from 1 to 6 employees.
- Jul 1, 2026
$14.5M grant from the Government of South Korea
For institutional investors. Book with your work email.
RX Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about RX's valuation, stock price, and market status.
Is RX a public or private company?
RX is a private company.
What is the current stock price of RX?
RX is a private company, so its shares have no public market price. Caplight tracks RX's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RX worth (valuation)?
Valuation information for RX is not publicly available.
Can I buy RX stock?
RX shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RX's last funding round?
RX's most recent funding round was Grant on July 1, 2026.
Who are the main investors in RX?
Key investors in RX include CKD Venture Capital, A Ventures, Bluepoint Partners, Company K Partners, Banks Foundation for Young Entrepreneurs.
Will RX IPO soon?
No public IPO plans have been announced for RX.
How can I track RX secondary market activity?
Caplight tracks bids, offers, and trades in RX's shares on secondary markets.